Biotechnology News and Research

RSS

IpAuctions to auction Predicant Biosciences patents, certain intellectual property of Perlegen

IpAuctions, Inc. is selling the patents and patent applications developed by Predicant Biosciences, formerly called BioSpect, and certain intellectual property of Perlegen.

1 Feb 2010

Enzo Biochem generating more than $100M in revenues annually

Enzo Biochem, Inc. is well positioned to benefit from the results of its transformation involving acquisitions, new managements at each of its major subsidiaries and a heightened focus on new life science, diagnostic and therapeutic products, Barry Weiner, President, told the annual meeting of shareholders today.

30 Jan 2010

Humedica to participate in 7th Annual Healthcare Conference

Humedica, a next-generation clinical informatics company, today announced that it will be presenting at Harvard Business School’s 7th Annual Healthcare Conference: “Policy Reform: An Inflection Point for Healthcare Management?” on Saturday, January 30, 2010.

30 Jan 2010

Delaware Bio members support bioscience educational initiatives

Last night at the second annual Delaware Bio Winterfest, Delaware BioScience Association provided the Junior Achievement of Delaware with financial support of $6555.00 to aid in the outfitting of the new Innovation hub.

30 Jan 2010

Musical video to teach basics of biotechnology

The video will be made available to high school students across North Carolina to help teach them how biotechnology harnesses cellular machinery to cure diseases, detect biohazards and manufacture new materials.

30 Jan 2010

Spectrum Pharmaceuticals receives $16M over apaziquone collaboration agreement

Spectrum Pharmaceuticals, Inc., announced today that it has received $15 million from Nippon Kayaku in connection with the collaboration agreement for apaziquone (EOquin®) announced on November 10, 2009, and $1 million from Handok Pharmaceuticals announced on November 23, 2009.

30 Jan 2010

Caldwell, IV discussed key elements on extension of human longevity at 7th Insurance Linked Securities Summit

Advanced Cell Technology, Inc. (OTCBB: ACTC), a biotechnology company applying cellular technology in the field of regenerative medicine, announced today that company Chairman and Chief Executive Officer, William M. Caldwell, IV, will be delivering a luncheon keynote address today at the 7th Insurance Linked Securities Summit, being held January 27-29, 2010 at the Roosevelt Hotel in New York City.

30 Jan 2010

Scientists currently working on 861 new cancer medicines

The Bienville Democrat in Arcadia, LA recently reported that America's pharmaceutical research and biotechnology companies have made great progress in treating cancers, introducing many new, breakthrough medicines.

30 Jan 2010

American PhRMA companies commit $25M in medicines, medical supplies and cash for Haiti relief efforts

As the need for health care assistance mounts after the recent catastrophic earthquake in Haiti, America's pharmaceutical research and biotechnology companies continue to provide help. So far, more than $25 million in medicines, medical supplies and cash have been committed to relief efforts – and that amount is still growing. The total does not include the contributions of PhRMA member company employees and the many companies committed to matching the pledges of their workers.

30 Jan 2010

Clinical results of MedImmune's pivotal trial for motavizumab published

MedImmune today announced that clinical results of its pivotal multinational, randomized, double-masked trial for motavizumab have been published in the current issue of the peer-reviewed publication, Pediatrics: Official Journal of the American Academy of Pediatrics.

30 Jan 2010

Rubicon Genomics reaches agreement with ZyGEM to market its PicoPlex single-cell amplification kits

Rubicon Genomics, Inc., a developer of pre-analytical amplification products that enable more comprehensive genetic analysis of clinical and research samples, announced today that it has reached agreement with ZyGEM to non-exclusively market Rubicon's PicoPlex™ single-cell amplification kits in Australia and New Zealand.

30 Jan 2010

Salient Pharmaceuticals receives TETF commercialization award for CASAD therapy commercialization

Houston Technology Center (HTC), announced today that client company Salient Pharmaceuticals received a $2 million commercialization award from the Texas Emerging Technology Fund (TETF) for the commercialization of their CASAD therapy, an all natural product used to prevent and treat some cancer therapy-induced side effects.

29 Jan 2010

LinkMed’s portfolio company receives order from Siemens AG for DIGNITY Carrier

LinkMed’s portfolio company has received an order from Siemens AG, Health Care Sector, Germany for its patient transportation solution, DIGNITY™ Carrier, for setting up patients for PET/CT imaging for special applications.

29 Jan 2010

Hitachi High-Technologies to begin shipment of Tabletop Microscope TM3000 from April

Hitachi High-Technologies Corporation today announced the development of the Tabletop Microscope TM3000. Shipments of the compact, affordably priced, and exceptionally user-friendly TM3000 are scheduled to start on April 1, 2010.

29 Jan 2010

Pretreating BPA plastic may be the key to dispose waste in an eco-friendly way

Just as cooking helps people digest food, pretreating polycarbonate plastic - source of a huge environmental headache because of its bisphenol A (BPA) content - may be the key to disposing of the waste in an eco-friendly way, scientists have found. Their new study is in ACS' Biomacromolecules, a monthly journal.

29 Jan 2010

QIAGEN hosts panel discussion to educate public about the emerging promise of personalized medicine

The treatment of illness has traditionally been based on the law of averages – what works best for the largest number of patients. As a result, billions of dollars are spent every year on treatments that could be ineffective or even harmful for some patients. What if doctors could tell with a simple test which course of treatment would be best for a particular patient?

From QIAGEN Manchester Limited 29 Jan 2010

Genzyme implements new annual and long-term incentive plans for senior executives

Genzyme Corporation announced today that it has adopted new annual and long-term incentive plans for senior executives that will be utilized beginning in 2010.

29 Jan 2010

Regis Technologies' 4-Aminopyridine manufacturing facility receives FDA's EIR and PAI approval

Regis Technologies, Inc., a leading provider of cGMP and non-GMP synthesis and separations services for active pharmaceutical ingredients (APIs) and intermediates, announced it has received an Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (FDA) stating that Regis passed the FDA’s pre-approval inspection (PAI) for its manufacture of 4-Aminopyridine the active ingredient in Ampyra™.

29 Jan 2010

Life Technologies collaborates with Ignite Institute to create genomic sequencing center

Life Technologies Corporation and the Ignite Institute for Individualized Health announced today a collaboration to create a ground-breaking genomic sequencing center at Ignite’s new facility in Northern Virginia.

28 Jan 2010

ChemoCentryx announces the initiation of Phase I clinical trial of CCX168

ChemoCentryx, Inc., today announced the initiation of a Phase I clinical trial of CCX168, an orally-administered small molecule designed to treat autoimmune diseases.

28 Jan 2010

Biotechnology News and Research

IpAuctions to auction Predicant Biosciences patents, certain intellectual property of Perlegen

Enzo Biochem generating more than $100M in revenues annually

Humedica to participate in 7th Annual Healthcare Conference

Delaware Bio members support bioscience educational initiatives

Musical video to teach basics of biotechnology

Spectrum Pharmaceuticals receives $16M over apaziquone collaboration agreement

Caldwell, IV discussed key elements on extension of human longevity at 7th Insurance Linked Securities Summit

Scientists currently working on 861 new cancer medicines

American PhRMA companies commit $25M in medicines, medical supplies and cash for Haiti relief efforts

Clinical results of MedImmune's pivotal trial for motavizumab published

Rubicon Genomics reaches agreement with ZyGEM to market its PicoPlex single-cell amplification kits

Salient Pharmaceuticals receives TETF commercialization award for CASAD therapy commercialization

LinkMed’s portfolio company receives order from Siemens AG for DIGNITY Carrier

Hitachi High-Technologies to begin shipment of Tabletop Microscope TM3000 from April

Pretreating BPA plastic may be the key to dispose waste in an eco-friendly way

QIAGEN hosts panel discussion to educate public about the emerging promise of personalized medicine

Genzyme implements new annual and long-term incentive plans for senior executives

Regis Technologies' 4-Aminopyridine manufacturing facility receives FDA's EIR and PAI approval

Life Technologies collaborates with Ignite Institute to create genomic sequencing center

ChemoCentryx announces the initiation of Phase I clinical trial of CCX168

Biotechnology eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News